vs

Side-by-side financial comparison of NPK International Inc. (NPKI) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

NPK International Inc. is the larger business by last-quarter revenue ($75.2M vs $44.6M, roughly 1.7× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs 13.8%). NPK International Inc. produced more free cash flow last quarter ($5.8M vs $-19.9M). Over the past eight quarters, NPK International Inc.'s revenue compounded faster (23.9% CAGR vs 7.3%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

NPKI vs PACB — Head-to-Head

Bigger by revenue
NPKI
NPKI
1.7× larger
NPKI
$75.2M
$44.6M
PACB
Growing faster (revenue YoY)
NPKI
NPKI
+16.9% gap
NPKI
30.7%
13.8%
PACB
More free cash flow
NPKI
NPKI
$25.7M more FCF
NPKI
$5.8M
$-19.9M
PACB
Faster 2-yr revenue CAGR
NPKI
NPKI
Annualised
NPKI
23.9%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPKI
NPKI
PACB
PACB
Revenue
$75.2M
$44.6M
Net Profit
$-40.4M
Gross Margin
37.7%
37.1%
Operating Margin
16.7%
-92.3%
Net Margin
-90.4%
Revenue YoY
30.7%
13.8%
Net Profit YoY
-1802.7%
EPS (diluted)
$0.17
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPKI
NPKI
PACB
PACB
Q4 25
$75.2M
$44.6M
Q3 25
$68.8M
$38.4M
Q2 25
$68.2M
$39.8M
Q1 25
$64.8M
$37.2M
Q4 24
$57.5M
$39.2M
Q3 24
$44.2M
$40.0M
Q2 24
$66.8M
$36.0M
Q1 24
$49.0M
$38.8M
Net Profit
NPKI
NPKI
PACB
PACB
Q4 25
$-40.4M
Q3 25
$5.7M
$-38.0M
Q2 25
$8.7M
$-41.9M
Q1 25
$10.0M
$-426.1M
Q4 24
$2.4M
Q3 24
$-174.3M
$-60.7M
Q2 24
$8.0M
$-173.3M
Q1 24
$7.3M
$-78.2M
Gross Margin
NPKI
NPKI
PACB
PACB
Q4 25
37.7%
37.1%
Q3 25
31.9%
41.4%
Q2 25
36.9%
36.9%
Q1 25
39.0%
-3.7%
Q4 24
39.2%
25.6%
Q3 24
27.5%
25.0%
Q2 24
37.2%
16.5%
Q1 24
36.0%
29.1%
Operating Margin
NPKI
NPKI
PACB
PACB
Q4 25
16.7%
-92.3%
Q3 25
13.2%
-101.1%
Q2 25
17.0%
-112.8%
Q1 25
20.9%
-1154.5%
Q4 24
20.2%
-390.1%
Q3 24
2.8%
-160.3%
Q2 24
18.7%
-488.3%
Q1 24
14.2%
-209.6%
Net Margin
NPKI
NPKI
PACB
PACB
Q4 25
-90.4%
Q3 25
8.2%
-98.9%
Q2 25
12.7%
-105.4%
Q1 25
15.4%
-1146.8%
Q4 24
6.0%
Q3 24
-394.3%
-151.9%
Q2 24
12.0%
-481.3%
Q1 24
14.9%
-201.4%
EPS (diluted)
NPKI
NPKI
PACB
PACB
Q4 25
$0.17
$-0.11
Q3 25
$0.07
$-0.13
Q2 25
$0.10
$-0.14
Q1 25
$0.11
$-1.44
Q4 24
$0.10
$-0.44
Q3 24
$-1.99
$-0.22
Q2 24
$0.09
$-0.64
Q1 24
$0.08
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPKI
NPKI
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$5.1M
$279.5M
Total DebtLower is stronger
$16.9M
Stockholders' EquityBook value
$351.2M
$5.3M
Total Assets
$441.8M
$784.1M
Debt / EquityLower = less leverage
0.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPKI
NPKI
PACB
PACB
Q4 25
$5.1M
$279.5M
Q3 25
$35.6M
$298.7M
Q2 25
$26.0M
$314.7M
Q1 25
$20.8M
$343.1M
Q4 24
$17.8M
$389.9M
Q3 24
$42.9M
$471.1M
Q2 24
$35.1M
$509.8M
Q1 24
$37.7M
$561.9M
Total Debt
NPKI
NPKI
PACB
PACB
Q4 25
$16.9M
Q3 25
$9.5M
Q2 25
$9.3M
Q1 25
$8.1M
Q4 24
$7.7M
Q3 24
$14.0M
Q2 24
$58.0M
Q1 24
$77.4M
Stockholders' Equity
NPKI
NPKI
PACB
PACB
Q4 25
$351.2M
$5.3M
Q3 25
$333.9M
$36.1M
Q2 25
$328.8M
$61.5M
Q1 25
$326.9M
$91.6M
Q4 24
$326.5M
$506.6M
Q3 24
$316.5M
$453.1M
Q2 24
$426.6M
$492.7M
Q1 24
$421.6M
$649.0M
Total Assets
NPKI
NPKI
PACB
PACB
Q4 25
$441.8M
$784.1M
Q3 25
$404.5M
$803.2M
Q2 25
$393.7M
$825.5M
Q1 25
$390.0M
$860.8M
Q4 24
$393.7M
$1.3B
Q3 24
$389.6M
$1.5B
Q2 24
$624.8M
$1.5B
Q1 24
$640.8M
$1.7B
Debt / Equity
NPKI
NPKI
PACB
PACB
Q4 25
0.05×
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.14×
Q1 24
0.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPKI
NPKI
PACB
PACB
Operating Cash FlowLast quarter
$18.0M
$-19.1M
Free Cash FlowOCF − Capex
$5.8M
$-19.9M
FCF MarginFCF / Revenue
7.6%
-44.6%
Capex IntensityCapex / Revenue
16.3%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.3M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPKI
NPKI
PACB
PACB
Q4 25
$18.0M
$-19.1M
Q3 25
$24.7M
$-18.7M
Q2 25
$21.4M
$-29.4M
Q1 25
$8.8M
$-44.1M
Q4 24
$-4.1M
$-30.6M
Q3 24
$2.8M
$-45.5M
Q2 24
$27.6M
$-54.3M
Q1 24
$11.9M
$-75.7M
Free Cash Flow
NPKI
NPKI
PACB
PACB
Q4 25
$5.8M
$-19.9M
Q3 25
$12.0M
$-18.8M
Q2 25
$9.7M
$-29.9M
Q1 25
$-1.2M
$-45.4M
Q4 24
$-17.7M
$-32.3M
Q3 24
$-6.7M
$-46.3M
Q2 24
$21.0M
$-55.7M
Q1 24
$-1.9M
$-79.6M
FCF Margin
NPKI
NPKI
PACB
PACB
Q4 25
7.6%
-44.6%
Q3 25
17.4%
-48.9%
Q2 25
14.3%
-75.3%
Q1 25
-1.8%
-122.3%
Q4 24
-30.8%
-82.3%
Q3 24
-15.2%
-115.7%
Q2 24
31.4%
-154.8%
Q1 24
-3.9%
-205.0%
Capex Intensity
NPKI
NPKI
PACB
PACB
Q4 25
16.3%
1.9%
Q3 25
18.5%
0.2%
Q2 25
17.1%
1.4%
Q1 25
15.5%
3.7%
Q4 24
23.6%
4.1%
Q3 24
21.4%
2.0%
Q2 24
9.9%
4.1%
Q1 24
28.3%
10.0%
Cash Conversion
NPKI
NPKI
PACB
PACB
Q4 25
Q3 25
4.37×
Q2 25
2.47×
Q1 25
0.88×
Q4 24
-12.93×
Q3 24
Q2 24
3.43×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPKI
NPKI

Rental Revenue$34.8M46%
Products$25.5M34%
Services$14.9M20%

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons